Corbus Pharmaceuticals (NASDAQ:CRBP) Posts Earnings Results, Misses Estimates By $0.54 EPS
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) released its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($1.81) EPS for the quarter, missing analysts’ consensus estimates of ($1.27) by ($0.54), FiscalAI reports. Corbus Pharmaceuticals Price Performance Corbus Pharmaceuticals stock traded up $0.09 during mid-day trading on Tuesday, reaching $3.60. 185,818 shares of the company […]
10 Nov 16:58 · The Markets Daily